Navigation Links
Cempra, Inc. Reports Fourth Quarter and Full Year 2012 Financial and Operating Results

rm debt

7,6239,504Total liabilities

9,030Commitments and ContingenciesRedeemable Convertible Preferred Shares

-94,514Shareholders' Equity (Deficit)Common shares; 100,000,000 shares authorized, no par value;533,839 shares issued and outstanding at December 31, 2011 andnone issued and outstanding at December 31, 2012

--Common stock; $.001 par value; none issued and outstanding atDecember 31, 2011 and 80,000,000 shares authorized; 24,903,774shares issued and outstanding at December 31, 2012

25-Additional paid-in capital

178,971-Deficit accumulated during the development stage

(121,226)(96,685)Total shareholders' equity  (deficit)

57,770(96,685)Total liabilities, redeemable convertible preferred sharesand shareholders' equity (deficit)

,859Condensed Consolidated Statements of Operations(unaudited; in thousands, except loss per share data)Three Months Ended December 31,20122011Revenues


$ -

$ -Operating expensesResearch and development

4,4131,458General and administrative


SOURCE Cempra, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. United States Patent and Trademark Office to Require Signed NDA Affects Many Reports Wysebridge
2. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
3. Soligenix Reports Year-End 2012 Financial Results and Highlights Recent Accomplishments
4. InterMune Reports Fourth Quarter And Full Year 2012 Financial Results And Business Highlights
5. Pharmacyclics Reports Results for Six and Three Months Ended December 31, 2012
6. Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on February 14, 2013
7. Neuland Labs Reports Third Quarter Fiscal Year 2013 Financial Results
8. Intraocular Lens (IOL) Market Worth $3.8 Billion By 2018 Say New Research Report at
9. Regenerative Medicine and Stem Cells Market Deals Analysis in New Research Report at
10. Cellular Therapy Market and Cord Blood Market 2013 Industry Research Report: MarketResearchReports.Biz
11. Neurocrine Biosciences Reports Fourth Quarter And Year End 2012 Results
Post Your Comments:
(Date:7/24/2014)... Calabasas, CA (PRWEB) July 24, 2014 ... advancing the Global Supply Chain of the biotech ... annual SCM Innovation Awards, brought to you by ... premiere global organization of supply chain management professionals ... be given to stakeholders of the Biotech industry ...
(Date:7/24/2014)... Security forces worldwide rely on sophisticated equipment, trained ... other public areas against terrorist attacks. A revolutionary ... about to make their job much easier. , ... Patolsky of Tel Aviv University ,s School of ... developed by the Herzliya company Tracense, picks up ...
(Date:7/24/2014)... natural and synthetic processes prefer to settle into ... energyit is within the realm of non-equilibrium conditions ... changes in energy and phases, such as temperature ... allow humans to regulate their body temperature, airplanes ... seismic activity. , But even though these ...
(Date:7/24/2014)... , July 24, 2014 SRI International ... with the National Institute of Allergy and Infectious Diseases ... conduct preclinical development of potential therapies for HIV infection ... to treat HIV and AIDS and the complications and ... microbicides for preventing sexual transmission of HIV. ...
Breaking Biology Technology:Call for Submission: BSMA’s Supply Chain Management Innovation Awards 2Call for Submission: BSMA’s Supply Chain Management Innovation Awards 3Nano-sized chip 'sniffs out' explosives far better than trained dogs 2New approach to form non-equilibrium structures 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3
... Oct. 20 Prometheus Research LLC has formed the ... including dashboards and reports. The group will draw on ... of building custom biomedical data management applications. ... said Andrzej Pienczykowski, Executive Vice President for Product Development ...
... Incorporated (NYSE: DGX ), the world,s leading ... its Board of Directors increased the company,s share repurchase ... first three quarters of 2010, the company repurchased approximately ... fully utilizing its previous authorization, which was granted in ...
... OAK RIDGE, Tenn., Oct. 19, 2010 -- The Cold ... National Laboratory,s High Flux Isotope Reactor and a complementary ... entered its commissioning phase. The CTAX uses "cold" ... magnetic excitations in materials. Cold neutrons are slower than ...
Cached Biology Technology:Prometheus Research Launches Solutions Group to Springboard HTSQL-based Solutions for Customers 2ORNL's research reactor revamps veteran neutron scattering tool 2
(Date:7/24/2014)... NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. ... the long-term, randomized, active control Phase 3 study of ... phosphate binder, for the treatment of hyperphosphatemia in patients ... study (PhosphatE binding and iRon delivery with FErric CiTrate ... Journal of the American Society of Nephrology ( ...
(Date:7/24/2014)... on different species of fish, according to a ... Exeter which tested fish anti-predator behaviour. , ... predator model when exposed to additional noise, whereas ... , Lead author Dr Irene Voellmy of Bristol,s ... many aquatic environments have increased substantially during the ...
(Date:7/24/2014)... its own microbial terroir, meaning the microbial populations found ... the product, creating the final flavor according to research ... and Environmental Microbiology . This is the first time ... brewery. , Many sake makers inoculate with both ... of the University of California, Davis, but he and ...
Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4The microbes make the sake brewery 2
... Researchers at Oregon State University have helped sequence ... for genetic improvements to related fruits like apples, peaches ... the journal Nature Genetics . "This will ... commercial strawberries," said OSU plant molecular biologist Todd Mockler, ...
... international research consortium has sequenced the genome of the ... Dec. 26 advance online edition of the journal ... possibilities for breeding tastier, hardier varieties of the berry ... the strawberry parts list," said the consortium,s leader Kevin ...
... brain tumours in larvae of the fruit fly Drosophila ... grow. The removal of some of these genes leads to ... for tumour development. The study, headed by ICREA researcher Cayetano ... . One of the characteristics of tumour cells ...
Cached Biology News:OSU helps decode strawberry genome in bid to improve fruit 2OSU helps decode strawberry genome in bid to improve fruit 3Georgia Tech team helps decode newly sequenced strawberry genome 2Georgia Tech team helps decode newly sequenced strawberry genome 3Some brain tumors mimic the genetic program of germline cells 2
dithiothreitol (DTT) Reactive Dyes and Chemicals Thiol-Reactive Dyes, Haptens and Quenchers Reducing Agents...
GRADIENT MAKER, 30 ML, 1 EA. Category: Protein Vertical Instruments....
Recombinant Rat Leptin, CF...
actin from rabbit muscle Cell Biology Cytoskeletal Probes Actin and Actin Probes...
Biology Products: